Video Experimental Relacionado
Updated: Jan 29, 2026
08:53
Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
10.4K
Nanofármaco proinmunotóxico dirigido al linfoma no Hodgkin asociado al SIDA
Shilin Chen1, Tong Qi1, Hongxu Peng2
1Department of Microbiology, Immunology, and Molecular Genetics, Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; UCLA AIDS Institute, Los Angeles, CA, USA; Department of Chemical and Biomolecular Engineering, UCLA, Los Angeles, CA, USA.
Resumen
Un nuevo nanofármaco, n(ch128.1Av/b-SO6)-CXCL13, se dirige y trata eficazmente el linfoma no Hodgkin asociado al SIDA (LNH-SIDA) mediante la administración de inmunotoxinas específicamente a las células tumorales. Este avance minimiza la toxicidad y muestra resultados prometedores para otros tipos de cáncer.
Área de la Ciencia:
- Oncología; Inmunología; Nanotecnología
Sus antecedentes:
- El linfoma no Hodgkin (LNH) de células B es un cáncer prevalente, particularmente agresivo en individuos infectados por el VIH, lo que lleva al LNH asociado al SIDA (LNH-SIDA). El receptor 1 de transferrina (TfR1/CD71) se sobreexpresa en las células de LNH, lo que presenta un objetivo terapéutico viable. Las inmunotoxinas existentes como ch128.1Av/b-SO6 muestran eficacia pero sufren de toxicidad sistémica.
Objetivo del estudio:
- Desarrollar un sistema de administración de fármacos dirigido para superar las limitaciones de la administración sistémica de inmunotoxinas para el LNH-SIDA. Crear un nanofármaco proinmunotóxico que libere específicamente su carga útil en el microambiente tumoral, reduciendo los efectos fuera del objetivo.
Principales métodos:
- Desarrollo de un nanofármaco proinmunotóxico, n(ch128.1Av/b-SO6)-CXCL13, que encapsula inmunotoxinas dentro de una cubierta polimérica. Estabilización del nanofármaco utilizando entrecruzadores peptídicos sensibles a la metaloproteinasa-2 (MMP-2) y conjugación con la quimiocina CXCL13 dirigida a células B. Evaluación de la eficacia y seguridad del nanofármaco en un modelo de ratón con xenoinjerto de LNH asociado al SIDA.
Principales resultados:
- El nanofármaco demostró una acumulación específica y liberación de inmunotoxinas dentro del microambiente tumoral, mediada por MMP-2. Se observó una mejora en la penetración tisular debido a las interacciones con los transportadores de colina. Se logró una eficacia antitumoral significativa en el modelo de xenoinjerto de LNH-SIDA con una toxicidad sistémica minimizada.
Conclusiones:
- El nanofármaco proinmunotóxico n(ch128.1Av/b-SO6)-CXCL13 ofrece una estrategia prometedora para la terapia dirigida en el LNH-SIDA. Este enfoque tiene el potencial de adaptarse para el tratamiento de otras neoplasias malignas aprovechando las enzimas tumorales específicas y las porciones de direccionamiento.
Videos de Conceptos Relacionados
02:57Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
01:26Targets for Drug Action: Overview
10.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.2K
01:22Target Cell Response to Hormones
5.7K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.7K
02:22Regulated mRNA Transport
7.0K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
7.0K
02:26Protein Networks
4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
01:58Fruit Development, Structure, and Function
25.2K
Fruits form from a mature flower ovary. As seeds develop from the ovules contained within, the ovary wall undergoes a series of complex changes to form fruit. In some fruits, such as soybeans, the ovary wall dries; in other fruits, such as grapes, it remains fleshy. In some cases, organs other than the ovary contribute to fruit formation; such fruits are called accessory fruits.
25.2K